Epidemiology

  1. Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study

    1. Marc Chadeau-Hyam
    2. Oliver Eales
    3. Barbara Bodinier
    4. Haowei Wang
    5. David Haw
    6. Matthew Whitaker
    7. Joshua Elliott
    8. Caroline E. Walters
    9. Jakob Jonnerby
    10. Christina Atchison
    11. Peter J. Diggle
    12. Andrew J. Page
    13. Deborah Ashby
    14. Wendy Barclay
    15. Graham Taylor
    16. Graham Cooke
    17. Helen Ward
    18. Ara Darzi
    19. Christl A. Donnelly
    20. Paul Elliott

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  2. mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021

    1. Huong Q. McLean
    2. David L. McClure
    3. Jennifer P. King
    4. Jennifer K. Meece
    5. David Pattinson
    6. Gabriele Neumann
    7. Yoshihiro Kawaoka
    8. Melissa A. Rolfes
    9. Edward A. Belongia

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. The impact of environmental mycobiomes on geographic variation in COVID-19 mortality

    1. Joshua Ladau
    2. Katrina Abuabara
    3. Angelica M. Walker
    4. Marcin P. Joachimiak
    5. Ishan Bansal
    6. Yulun Wu
    7. Elijah B. Hoffman
    8. Chaincy Kuo
    9. Nicola Falco
    10. Jared Streich
    11. Mark J. van der Laan
    12. Haruko M. Wainwright
    13. Eoin L. Brodie
    14. Matthias Hess
    15. Daniel Jacobson
    16. James B. Brown

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Waning of mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar

    1. Laith J. Abu-Raddad
    2. Hiam Chemaitelly
    3. Houssein H. Ayoub
    4. Hadi M. Yassine
    5. Fatiha M. Benslimane
    6. Hebah A. Al Khatib
    7. Patrick Tang
    8. Mohammad R. Hasan
    9. Peter Coyle
    10. Zaina Al Kanaani
    11. Einas Al Kuwari
    12. Andrew Jeremijenko
    13. Anvar Hassan Kaleeckal
    14. Ali Nizar Latif
    15. Riyazuddin Mohammad Shaik
    16. Hanan F. Abdul Rahim
    17. Gheyath K. Nasrallah
    18. Mohamed Ghaith Al Kuwari
    19. Adeel A. Butt
    20. Hamad Eid Al Romaihi
    21. Mohamed H. Al-Thani
    22. Abdullatif Al Khal
    23. Roberto Bertollini

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  5. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies

    1. Isabel Bergeri
    2. Mairead G. Whelan
    3. Harriet Ware
    4. Lorenzo Subissi
    5. Anthony Nardone
    6. Hannah C. Lewis
    7. Zihan Li
    8. Xiaomeng Ma
    9. Marta Valenciano
    10. Brianna Cheng
    11. Lubna Al Ariqi
    12. Arash Rashidian
    13. Joseph Okeibunor
    14. Tasnim Azim
    15. Pushpa Wijesinghe
    16. Linh-Vi Le
    17. Aisling Vaughan
    18. Richard Pebody
    19. Andrea Vicari
    20. Tingting Yan
    21. Mercedes Yanes-Lane
    22. Christian Cao
    23. David A. Clifton
    24. Matthew P. Cheng
    25. Jesse Papenburg
    26. David Buckeridge
    27. Niklas Bobrovitz
    28. Rahul K. Arora
    29. Maria D. Van Kerkhove
    30. Unity Studies Collaborator Group

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Differential Risk of SARS-CoV-2 Infection by Occupation: Evidence from the Virus Watch prospective cohort study in England and Wales

    1. Sarah Beale
    2. Susan Hoskins
    3. Thomas Byrne
    4. Wing Lam Erica Fong
    5. Ellen Fragaszy
    6. Cyril Geismar
    7. Jana Kovar
    8. Annalan M D Navaratnam
    9. Vincent Nguyen
    10. Parth Patel
    11. Alexei Yavlinsky
    12. Anne M Johnson
    13. Martie Van Tongeren
    14. Robert W Aldridge
    15. Andrew Hayward

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Antibody-Mediated Immunogenicity Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Following Priming, Boosting, and Hybrid Immunity: Insights From 11 Months of Follow-up of a Healthcare Worker Cohort in Israel, December 2020–October 2021

    1. Michael Edelstein
    2. Karine Wiegler Beiruti
    3. Hila Ben-Amram
    4. Naor Bar-Zeev
    5. Christian Sussan
    6. Hani Asulin
    7. David Strauss
    8. Younes Bathish
    9. Salman Zarka
    10. Kamal Abu Jabal

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Workplace contact patterns in England during the COVID-19 pandemic: Analysis of the Virus Watch prospective cohort study

    1. Sarah Beale
    2. Susan Hoskins
    3. Thomas Byrne
    4. Wing Lam Erica Fong
    5. Ellen Fragaszy
    6. Cyril Geismar
    7. Jana Kovar
    8. Annalan M.D. Navaratnam
    9. Vincent Nguyen
    10. Parth Patel
    11. Alexei Yavlinsky
    12. Anne M. Johnson
    13. Martie Van Tongeren
    14. Robert W. Aldridge
    15. Andrew Hayward

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Final sizes and durations of new COVID-19 pandemic waves in Poland and Germany predicted by generalized SIR model

    1. Igor Nesteruk

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort

    1. Dominik Menges
    2. Kyra D. Zens
    3. Tala Ballouz
    4. Nicole Caduff
    5. Daniel Llanas-Cornejo
    6. Hélène E. Aschmann
    7. Anja Domenghino
    8. Céline Pellaton
    9. Matthieu Perreau
    10. Craig Fenwick
    11. Giuseppe Pantaleo
    12. Christian R. Kahlert
    13. Christian Münz
    14. Milo A. Puhan
    15. Jan S. Fehr

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 140 of 465 Next